Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 6 Months Ended
May 31, 2012
May 31, 2011
Cash Flows from Operating Activities:    
Net (loss) income $ (4,906,993) $ 410,848
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization expense 207,901 268,724
Loss on sale of property and equipment 7,210 1,214
Compensatory element of stock options 1,019,339 92,965
Provision for doubtful accounts 466,997 94,735
Equity in losses of affiliate 77,664 56,212
Loss on extinguishment of revenue sharing agreements 1,281,945  
Deferred income tax expense 1,718,919  
Changes in assets and liabilities:    
Restricted cash 49,367  
Accounts receivable (419,266) (1,056,529)
Prepaid expenses and other current assets (62,030) (259,758)
Deposits and other assets 10,001 11,993
Accounts payable 170,281 164,392
Accrued expenses 163,501 181,303
Deferred consulting obligation (58,411) (54,467)
Deferred revenue (111,404) 326,906
Net cash (used in) provided by operating activities (384,979) 238,538
Cash flows from investing activities:    
Purchases of property and equipment (116,527) (362,380)
Purchases of marketable securities and other investments (13,380)  
Proceeds from sale of marketable securities and other investments 1,008,404 20,000
Investments in patents (20,385) (60,145)
Net cash provided by (used in) investing activities 858,112 (402,525)
Cash flows from financing activities:    
Extinguishment of revenue sharing agreements (2,576,000)  
Treasury stock purchases (1,400,471)  
Proceeds from the exercise of stock options   5,471
Net cash (used in) provided by financing activities (3,976,471) 5,471
Decrease in cash and cash equivalents (3,503,338) (158,516)
Cash and cash equivalents - beginning of year 6,305,095 8,369,537
Cash and cash equivalents - end of year $ 2,801,757 $ 8,211,021